ClinicalTrials.gg
Enrolling by invitationNCT02040714IPSG1Updated May 6, 2025

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

An observational study in Legg Calve Perthes Disease, sponsored by Texas Scottish Rite Hospital for Children. Enrolling by invitation at 46 sites in 15 countries. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2025-05-06.

Sponsored by Texas Scottish Rite Hospital for Children · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
1 Year to 18 Years
Sex
All
01

Study summary

Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon enough to have a sufficient number of patients from a single institution to perform a definitive prospective study comparing the results of current treatments. The present study will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP) Disease and collect information regarding their presentation, treatment, and outcomes in the course of receiving currently available treatments.

This study seeks to compare the outcomes of current treatments in the management of different age groups (ages 1-6, 6-8, 8-11, >11) of patients with Perthes disease at two- and five-year followup and at skeletal maturity. For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a patient receives is determined through physician treatment expertise, and is not pre-determined by the study.

Read the detailed description

Approximately 50 pediatric orthopaedic surgeons from pediatric centers in the US and other countries have agreed to participate in this database as members of the International Perthes Study Group (IPSG). TSRH will be the lead center. Sites who agree to participate will seek IRB approval from their own institutions. Data will be collected prospectively and entered into REDCap (Research Electronic Data Capture), a browser-based research database.

1-6 Cohort: For the 1-6 age patient group, patients involved in any treatment will be asked to participate in the study.

6-8 Cohort: For the 6-8 age patient group, patients presenting in an early stage of the disease (stage I or IIa), the surgeons who treat their patients with one of the following three treatment regimens currently used in practice will be asked to participate in the study :

  1. Non-operative management (i.e., no osteotomy but can include soft tissue release);
  2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty).

8-11 Cohort: For the 8-11 patient age group, patients presenting in an early stage of the disease (stage I or IIa), the surgeons who treat their patients with one of the following treatment regiments currently used in practice will be asked to participate in the study:

  1. Non-operative management (i.e., no osteotomy);
  2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) followed by 6 weeks of postoperative non-weight bearing; and,
  3. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) followed by 6 months of postoperative non-weight bearing.

>11 Cohort Registry: For the >11 patient age group, we will collect prospective data from surgeons who are currently treating their patients with any treatment regimens.

Patients who present to an IPSG member or their group during the late stages of the disease (stage IIb or stage III) will also be arranged into four separate age cohorts, identical to the list above. We will collect prospective data for these cases, as well.

Regardless of the patient's stage at enrollment, the patient's age at diagnosis or assigned cohort, the following data will be collected: information regarding patient characteristics at presentation, physical exam findings, responses to Perthes patient and/or outcomes questionnaires, and results of radiographic and MR imaging.

Participants will be assigned a unique study number. A secure web application, REDCap, will be used to capture and store research information including radiographic and MR images, clinical information, and de-identified outcomes questionnaire responses. Data will be transmitted and stored on a secure and dedicated server for the purpose of this study.

02

Conditions studied

  • Legg Calve Perthes Disease

Keywords

  • femur head necrosis
  • hip
  • pediatric orthopedics
  • MRI
  • Osteonecrosis
  • Bone diseases
  • Legg Calve Perthes Syndrome
03

In context

Legg-Calve-Perthes Disease

25 studies on the registry are indexed under Legg-Calve-Perthes Disease; 7 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 150 across 10 observational studies indexed under Legg-Calve-Perthes Disease.

Browse Legg-Calve-Perthes Disease studies →

Lead sponsor

Texas Scottish Rite Hospital for Children is the lead sponsor of 18 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants with a recent diagnosis of Perthes disease that are being followed by a participating orthopedic surgeon. Participants are invited to participate during a visit to their treating hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with Legg-Calvé-Perthes disease
  • Between age 1-18
  • Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or therapy are also eligible.

Exclusion criteria

Exclusion Criteria:

  • Patients with previous surgical treatment on the affected hip
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Nonoperative management between ages 6-8 in early stage

    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Nonoperative Observation

  • Operative management between age 6-8 in early stage

    Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the early stage of the disease process

    Procedure: Osteotomy + Long Term Non-Weight Bearing · Procedure: Osteotomy + Short Term Non-Weight Bearing

  • Nonoperative management between age 8-11 in early stage

    Patients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.

    Procedure: Nonoperative Observation

  • Operative containment with short-term non-weightbearing in early stage

    As per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.

    Procedure: Osteotomy + Short Term Non-Weight Bearing

  • Operative containment with prolonged non-weightbearing in early stage

    As per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.

    Procedure: Osteotomy + Long Term Non-Weight Bearing

  • Operative containment for over 11 age group

    Patients presenting over age 11 may receive multiple drilling and be non weight bearing for up to 6 months according to the treating physician's preference. Patients with application of fixator (arthrodiastasis) will be studied in this cohort arm as well, which typically involved 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal. Other surgical techniques may be included, however these are the most common for this age group.

    Procedure: Osteotomy + Long Term Non-Weight Bearing · Procedure: Osteotomy + Short Term Non-Weight Bearing · Procedure: Multiple Epiphyseal Drilling

  • Nonoperative management in over 11 age group

    Patients will be non-weight bearing and receive physical therapy according to the physician preferences.

    Procedure: Nonoperative Observation

  • Nonoperative management in 1-6 age group

    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Nonoperative Observation

  • Operative management in 1-6 age group

    The choice of osteotomy management with containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Osteotomy + Long Term Non-Weight Bearing · Procedure: Osteotomy + Short Term Non-Weight Bearing · Procedure: Multiple Epiphyseal Drilling

  • Late Stage Bracing group

    Patients presenting with \<= 20 degrees of abduction on a maximum abduction x-ray treated with bracing who also present in the late stages of the disease (Waldenstrom Stage IIb or IIIa).The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Nonoperative Observation

  • Late Stage Symptomatic treatment group

    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated symptomatically. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Nonoperative Observation

  • Late Stage Surgical Containment group

    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated with surgical containment. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

    Procedure: Osteotomy + Long Term Non-Weight Bearing · Procedure: Osteotomy + Short Term Non-Weight Bearing · Procedure: Multiple Epiphyseal Drilling

Interventions

  • ProcedureOsteotomy + Long Term Non-Weight Bearing

    Surgical procedure that improves femoral head containment, plus a post-operative protocol that requires patient to maintain non-weight bearing for 6 months.

  • ProcedureOsteotomy + Short Term Non-Weight Bearing

    Surgical procedure that improves femoral head containment, plus a post-operative protocol that allows early return to function after 6 weeks of non-weight bearing.

  • ProcedureNonoperative Observation

    Group will not undergo any surgical or invasive procedures during course of treatment.

  • ProcedureMultiple Epiphyseal Drilling

    Multiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.

06

What researchers measure

Primary outcomes

  1. Sphericity deviation score of the femoral head

    The primary outcome for each age group will be a quantitative estimate of the sphericity of the femoral head as a measure of femoral head deformity. A more deformed head will be less spherical. Greater deformity leads to an increased risk of arthritis early in life.

    Time frame: 5 years post intervention

Secondary outcomes

  1. Perfusion percentage

    The perfusion percentage is a measure of the amount of blood flow in the femoral head relative to the volume of the whole head. This measure is calculated from the perfusion MRI images that are collected just prior to the application of the intervention.

    Time frame: Just after diagnosis of Perthes disease

Other outcomes

  1. Stulberg classification

    The Stulberg classification is a categorical system used to describe the shape of the femoral head that is traditionally used to evaluate outcomes and arthritis risk for patients with Perthes disease.

    Time frame: at 2 years and 5 years post intervention

07

Study locations

46 sites
08

References and documents

Individual participant data

Plan to share: No — Patient enrolled in study will be deidentified (a specific ID will be assigned to participants) in each respective site, Each site will be in charge of entering their respective data in a main database. Data analysis of this collective data will be done mainly through the host site.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2012, a primary completion of Sep 2032 and a completion of Sep 2032. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2014
First posted
Jan 20, 2014
Start
Aug 2012
Primary completionEst.
Sep 2032
CompletionEst.
Sep 2032
Last update
May 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02040714
Lead sponsor
Texas Scottish Rite Hospital for Children
Collaborators
Alberta Children's Hospital, Alfred I. duPont Hospital for Children, Le Bonheur Children's Hospital, Children's Hospital Colorado, Children's Hospital Los Angeles, Children's National Research Institute, Children's Healthcare of Atlanta, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Columbia University, Connecticut Children's Medical Center, Gillette Children's Specialty Healthcare, Boston Children's Hospital, Johns Hopkins University, Kaiser Permanente, Kasturba Medical College, Montefiore Medical Center, Nationwide Children's Hospital, NYU Langone Health, OrthoCarolina Research Institute, Inc., University of Sao Paulo General Hospital, Seoul National University Childrens Hospital, Shriners Hospitals for Children, University Hospital Southampton NHS Foundation Trust, Baylor College of Medicine, Universitätsklinikum Hamburg-Eppendorf, Ann & Robert H Lurie Children's Hospital of Chicago, British Columbia Children's Hospital, Children's of Alabama, Hospital Infantil Universitario Niño Jesús, Madrid, Spain, University of Oklahoma, Oregon Health and Science University, Rady Children's Hospital, San Diego, San Jorge Children's Hospital (Puerto Rico), University College Dublin, Tianjin Children's Hospital, University Hospital Schleswig-Holstein, University of California, San Francisco, University of Haifa, Uppsala University, Medical University of Lodz, Oslo University Hospital, Seattle Children's Hospital, Mayo Clinic
Responsible party
Harry Kim, MD (Director of Research, Texas Scottish Rite Hospital for Children) — Principal investigator
First posted
Jan 20, 2014
Start date
Aug 2012
Primary completion
Sep 2032 (estimated)
Completion
Sep 2032 (estimated)
Last update
May 6, 2025

Study contacts

Harry KW Kim, MD, MS
study chair · Texas Scottish Rite Hospital for Children

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion